Yıl: 2020 Cilt: 5 Sayı: 1 Sayfa Aralığı: 41 - 46 Metin Dili: İngilizce DOI: DOI: 10.5152/cjms.2020.890 İndeks Tarihi: 21-10-2020

Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life

Öz:
BACKGROUND/AIMSVitiligo is an acquired, idiopathic, generally progressive pigmentation disorder of an unknown etiology. Vitiligo usually begins duringchildhood or adolescence. This study aimed to evaluate the clinical and demographic characteristics of this disease as well as understandits impact on patient quality of life (QoL).MATERIAL and METHODSThirty-one vitiligo patients aged 5–16 years who visited the outpatient dermatology clinic were included in the study. The demographicinformation of all the patients was collected. A complete clinical examination was performed, and the disease-related features wererecorded. Moreover, all the patients completed the children’s dermatology life quality index (CDLQI).RESULTSOf the 31 patients, 20 were girls (64.5%), and 11 were boys (35.5%). The mean patient age was 10.33±4.19 years. Vitiligo vulgaris was themost common (51.6%) clinical type of vitiligo. The most commonly involved areas were the trunk (54.9%), face (54.9%), and extremities(41.7%). In the study group, 32.3% of the patients (10 of 31) had an accompanying autoimmune disease. The median CDLQI score of thepatient group was 6 (min–max: 0–22). There was a significant correlation between patient age and CDLQI score (r=0.369, p=0.041).CONCLUSIONVitiligo has a different clinicoepidemiological profile in children and adolescents. This disease significantly lowers the patient’s QoL. Ourstudy found a significant correlation between patient age and CDLQI score. In clinical practice, it is important to remember that vitiligo isnot only a cosmetic disorder; it may negatively affect multiple aspects of the patient’s QoL.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Dertlioglu SB, Cicek D, Balci DD, Halisdemir N. Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. Int J Dermatol 2013; 52(1): 96-101. [CrossRef]
  • 2. Kruger C, Panske A, Schallreuter KU. Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo. Int J Dermatol 2014; 53(1): 43-50. [CrossRef]
  • 3. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int J Dermatol 1992; 31(9): 621-3. [CrossRef]
  • 4. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132(6): 942-9. [CrossRef]
  • 5. Balcı DD, Sangun O, Inandı T. Cross-validation of the Turkish version of the children’s dermatology life quality index. J Turk Acad Dermatol 2007; 1(4): 1-5.
  • 6. Olsen JR, Gallacher J, Finlay AY, Piguet V, Francis NA. Quality of life impact of childhood skin conditions measured using the Children’s Dermatology Life Quality Index (CDLQI): a meta-analysis. Br J Dermatol 2016; 174(4): 853-61. [CrossRef]
  • 7. Schwartz R, Sepulveda JE, Quintana T. [Possible role of psychological and environmental factors in the genesis of childhood vitiligo]. Rev Med Chil 2009; 137(1): 53-62. [CrossRef]
  • 8. Agarwal S, Ramam M, Sharma VK, Khandpur S, Pal H, Pandey RM. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo. Br J Dermatol 2005; 153(1): 163-6. [CrossRef]
  • 9. Bilgic O, Bilgic A, Akis HK, Eskioglu F, Kilic EZ. Depression, anxiety and health-related quality of life in children and adolescents with vitiligo. Clin Exp Dermatol 2011; 36(4): 360-5. [CrossRef]
  • 10. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42(2 Pt 1): 245-53. [CrossRef]
  • 11. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol 2014; 31(3): 309-18. [CrossRef]
  • 12. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38(5 Pt 1): 647-66; quiz 67-8. [CrossRef]
  • 13. Halder RM. Childhood vitiligo. Clin Dermatol 1997; 15(6): 899-906. [CrossRef]
  • 14. Halder RM, Grimes PE, Cowan CA, Enterline JA, Chakrabarti SG, Kenney JA, Jr. Childhood vitiligo. J Am Acad Dermatol 1987; 16(5 Pt 1): 948-54. [CrossRef]
  • 15. Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 2003; 20(3): 207-10. [CrossRef]
  • 16. Pajvani U, Ahmad N, Wiley A, Levy RM, Kundu R, Mancini AJ, et al. The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol 2006; 55(2): 238-44. [CrossRef]
  • 17. Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol 2000; 17(3): 189-93. [CrossRef]
  • 18. Hu Z, Liu JB, Ma SS, Yang S, Zhang XJ. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol 2006; 23(2): 114-6. [CrossRef]
  • 19. Agarwal S, Gupta S, Ojha A, Sinha R. Childhood vitiligo: clinicoepidemiologic profile of 268 children from the Kumaun region of Uttarakhand, India. Pediatr Dermatol 2013; 30(3): 348-53. [CrossRef]
  • 20. Nicolaidou E, Antoniou C, Miniati A, Lagogianni E, Matekovits A, Stratigos A, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol 2012; 66(6): 954-8. [CrossRef]
  • 21. Dawber RP. Clinical associations of vitiligo. Postgrad Med J 1970; 46(535): 276-7. [CrossRef]
  • 22. Palit A, Inamadar AC. Childhood vitiligo. Indian J Dermatol Venereol Leprol 2012; 78(1): 30-41. [CrossRef]
  • 23. Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994; 188(4): 269-75. [CrossRef]
  • 24. Lotti T, Zanardelli M, D’Erme AM. Vitiligo: what’s new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr 2014; 164(13-14): 278-85. [CrossRef]
APA karaosmanoğlu n, Özdemir Çetinkaya P, İmren I, Kıratlı Nalbant E, Karaaslan E (2020). Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. , 41 - 46. DOI: 10.5152/cjms.2020.890
Chicago karaosmanoğlu nermin,Özdemir Çetinkaya Pınar,İmren Işıl Göğem,Kıratlı Nalbant Esra,Karaaslan Engin Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. (2020): 41 - 46. DOI: 10.5152/cjms.2020.890
MLA karaosmanoğlu nermin,Özdemir Çetinkaya Pınar,İmren Işıl Göğem,Kıratlı Nalbant Esra,Karaaslan Engin Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. , 2020, ss.41 - 46. DOI: 10.5152/cjms.2020.890
AMA karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. . 2020; 41 - 46. DOI: 10.5152/cjms.2020.890
Vancouver karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. . 2020; 41 - 46. DOI: 10.5152/cjms.2020.890
IEEE karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E "Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life." , ss.41 - 46, 2020. DOI: 10.5152/cjms.2020.890
ISNAD karaosmanoğlu, nermin vd. "Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life". (2020), 41-46. https://doi.org/DOI: 10.5152/cjms.2020.890
APA karaosmanoğlu n, Özdemir Çetinkaya P, İmren I, Kıratlı Nalbant E, Karaaslan E (2020). Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. Cyprus Journal of Medical Sciences, 5(1), 41 - 46. DOI: 10.5152/cjms.2020.890
Chicago karaosmanoğlu nermin,Özdemir Çetinkaya Pınar,İmren Işıl Göğem,Kıratlı Nalbant Esra,Karaaslan Engin Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. Cyprus Journal of Medical Sciences 5, no.1 (2020): 41 - 46. DOI: 10.5152/cjms.2020.890
MLA karaosmanoğlu nermin,Özdemir Çetinkaya Pınar,İmren Işıl Göğem,Kıratlı Nalbant Esra,Karaaslan Engin Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. Cyprus Journal of Medical Sciences, vol.5, no.1, 2020, ss.41 - 46. DOI: 10.5152/cjms.2020.890
AMA karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. Cyprus Journal of Medical Sciences. 2020; 5(1): 41 - 46. DOI: 10.5152/cjms.2020.890
Vancouver karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life. Cyprus Journal of Medical Sciences. 2020; 5(1): 41 - 46. DOI: 10.5152/cjms.2020.890
IEEE karaosmanoğlu n,Özdemir Çetinkaya P,İmren I,Kıratlı Nalbant E,Karaaslan E "Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life." Cyprus Journal of Medical Sciences, 5, ss.41 - 46, 2020. DOI: 10.5152/cjms.2020.890
ISNAD karaosmanoğlu, nermin vd. "Childhood and Adolescence Vitiligo: Clinicoepidemiological Profile and Its Impact on Quality of Life". Cyprus Journal of Medical Sciences 5/1 (2020), 41-46. https://doi.org/DOI: 10.5152/cjms.2020.890